AMJB structured notes: high-yield auto-callable deal from JPMorgan
JPMorgan Chase Financial Company LLC is offering auto callable contingent interest notes linked individually to the Nasdaq-100® Technology Sector IndexSM, the Russell 2000® Index and the Utilities Select Sector SPDR® Fund, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes pay a monthly contingent interest rate of at least 9.05% per annum only if on each Review Date the closing value of every underlying is at or above 60% of its Initial Value. The notes may be automatically called starting on November 30, 2026 if, on an applicable Review Date (other than the first through eleventh and final), each underlying is at or above its Initial Value, in which case investors receive $1,000 per note plus the applicable contingent interest and no further payments. If the notes are not called and any underlying finishes below its 60% Trigger Value at maturity on December 1, 2028, investors lose 1% of principal for each 1% decline of the least performing underlying and can lose their entire investment. The notes are unsecured obligations with an estimated value of approximately $963.60 per $1,000 principal amount note if priced on the indicated date, and are subject to market, sector, liquidity, credit and tax risks.
Positive
- None.
Negative
- None.
FAQ
What are the JPMorgan AMJB auto callable contingent interest notes?
The notes are structured debt securities of JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co., that pay conditional monthly interest and may be automatically called based on the performance of three underlyings: the Nasdaq-100® Technology Sector IndexSM, the Russell 2000® Index and the Utilities Select Sector SPDR® Fund.
How does the 9.05% contingent interest on the AMJB notes work?
For each $1,000 note, investors are scheduled to receive a Contingent Interest Payment of at least $7.5417 per month (at least 9.05% per annum) only if on the relevant Review Date the closing value of each underlying is at or above 60% of its Initial Value; if any is below that barrier, no interest is paid for that period.
When can the AMJB notes be automatically called?
The notes can be automatically called on any Review Date other than the first through eleventh and final Review Dates if the closing value of each underlying is at or above its Initial Value; investors then receive $1,000 per note plus the applicable contingent interest on the corresponding Call Settlement Date.
What happens at maturity of the JPMorgan AMJB notes?
If the notes have not been called and the Final Value of each underlying is at or above its 60% Trigger Value, investors receive $1,000 per note plus the last contingent interest. If any underlying finishes below its Trigger Value, the maturity payment becomes $1,000 plus $1,000 times the return of the least performing underlying, so losses can exceed 40% and reach 100% of principal.
What are the main risks of investing in these AMJB structured notes?
Key risks include loss of principal if the least performing underlying breaches its Trigger Value, the possibility of no interest payments if any underlying stays below its Interest Barrier on Review Dates, exposure to sector and small-cap equity volatility, credit risk of JPMorgan Financial and JPMorgan Chase & Co., and limited liquidity because the notes will not be listed on an exchange.
What is the estimated value of the AMJB notes versus the $1,000 price to public?
If priced on the indicated date, the estimated value would be approximately $963.60 per $1,000 principal amount note, and the final estimated value disclosed at pricing will not be less than $930.00. The difference from the $1,000 price reflects selling commissions, projected hedging profits or losses and hedging costs.
How are the AMJB notes treated for U.S. federal income tax purposes?
For U.S. federal income tax purposes, the issuer intends to treat the notes as prepaid forward contracts with associated contingent coupons, with Contingent Interest Payments taxed as ordinary income, and notes that alternative treatments are possible; non-U.S. holders may be subject to 30% withholding on contingent interest subject to treaty relief and certification.